AGIOS PHARMACEUTICALS, INC.·4

Jun 17, 5:20 PM ET

Smith Cynthia 4

4 · AGIOS PHARMACEUTICALS, INC. · Filed Jun 17, 2024

Insider Transaction Report

Form 4
Period: 2024-06-13
Transactions
  • Exercise/Conversion

    Common stock

    2024-06-13+3,3885,690 total
  • Exercise/Conversion

    Restricted stock units

    2024-06-133,3880 total
    Common stock (3,388 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F2]The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Documents

1 file
  • 4
    wk-form4_1718659239.xmlPrimary

    FORM 4